Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 31, 2023

SELL
$90.94 - $199.54 $1.6 Million - $3.51 Million
-17,600 Reduced 66.67%
8,800 $800,000
Q1 2023

May 11, 2023

BUY
$132.34 - $159.14 $3.4 Million - $4.09 Million
25,700 Added 3671.43%
26,400 $4.2 Million
Q3 2022

Nov 09, 2022

BUY
$95.28 - $116.93 $66,696 - $81,851
700 New
700 $69.7 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $246B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Paradigm Asset Management CO LLC Portfolio

Follow Paradigm Asset Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Asset Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Asset Management CO LLC with notifications on news.